Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview
Autoimmune hepatitis (AIH) is a unique form of immune-mediated disease that attacks the liver through a variety of immune mechanisms. The outcomes of AIH are either acute liver disease, which can be fatal, or, more commonly, chronic progressive liver disease, which can lead to decompensated liver ci...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Autoimmune Diseases |
Online Access: | http://dx.doi.org/10.1155/2012/312817 |
id |
doaj-6edc6f529e3f4c1692eafe06e8873aa7 |
---|---|
record_format |
Article |
spelling |
doaj-6edc6f529e3f4c1692eafe06e8873aa72020-11-25T02:03:27ZengHindawi LimitedAutoimmune Diseases2090-04222090-04302012-01-01201210.1155/2012/312817312817Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical OverviewHind I. Fallatah0Hisham O. Akbar1Medical Department, Arab Board and Saudi Board of Internal Medicine, MACP, King Abdul Aziz University Hospital, P.O. Box 9714, Jeddah 21423, Saudi ArabiaKing Abdul Aziz University Hospital, Jeddah, Saudi ArabiaAutoimmune hepatitis (AIH) is a unique form of immune-mediated disease that attacks the liver through a variety of immune mechanisms. The outcomes of AIH are either acute liver disease, which can be fatal, or, more commonly, chronic progressive liver disease, which can lead to decompensated liver cirrhosis if left untreated. AIH has characteristic immunological, and pathological, features that are important for the establishment of the diagnosis. More importantly, most patients with AIH have a favorable response to treatment with prednisolone and azathioprine, although some patients with refractory AIH or more aggressive disease require more potent immune-suppressant agents, such as cyclosporine or Mycophenolate Mofetil. In this paper, we discuss the immunological, pathological and clinical features of AIH, as well as the standard and alternative treatments for AIH.http://dx.doi.org/10.1155/2012/312817 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hind I. Fallatah Hisham O. Akbar |
spellingShingle |
Hind I. Fallatah Hisham O. Akbar Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview Autoimmune Diseases |
author_facet |
Hind I. Fallatah Hisham O. Akbar |
author_sort |
Hind I. Fallatah |
title |
Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview |
title_short |
Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview |
title_full |
Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview |
title_fullStr |
Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview |
title_full_unstemmed |
Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview |
title_sort |
autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview |
publisher |
Hindawi Limited |
series |
Autoimmune Diseases |
issn |
2090-0422 2090-0430 |
publishDate |
2012-01-01 |
description |
Autoimmune hepatitis (AIH) is a unique form of immune-mediated disease that attacks the liver through a variety of immune mechanisms. The outcomes of AIH are either acute liver disease, which can be fatal, or, more commonly, chronic progressive liver disease, which can lead to decompensated liver cirrhosis if left untreated. AIH has characteristic immunological, and pathological, features that are important for the establishment of the diagnosis. More importantly, most patients with AIH have a favorable response to treatment with prednisolone and azathioprine, although some patients with refractory AIH or more aggressive disease require more potent immune-suppressant agents, such as cyclosporine or Mycophenolate Mofetil. In this paper, we discuss the immunological, pathological and clinical features of AIH, as well as the standard and alternative treatments for AIH. |
url |
http://dx.doi.org/10.1155/2012/312817 |
work_keys_str_mv |
AT hindifallatah autoimmunehepatitisasauniqueformofanautoimmuneliverdiseaseimmunologicalaspectsandclinicaloverview AT hishamoakbar autoimmunehepatitisasauniqueformofanautoimmuneliverdiseaseimmunologicalaspectsandclinicaloverview |
_version_ |
1724948135155859456 |